United Therapeutics Shares Down 20.1% Since SmarTrend's Sell Call (UTHR)

SmarTrend identified a Downtrend for United Therapeutics (NASDAQ:UTHR) on January 6th, 2016 at $147.74. In approximately 1 month, United Therapeutics has returned 20.09% as of today's recent price of...